相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors
Barliz Waissengein et al.
CLINICAL RESEARCH IN CARDIOLOGY (2023)
Diagnosis and Treatment of Acute Myocarditis A Review
Enrico Ammirati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Alan J. Korman et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T
Jeanne du Fay de Lavallaz et al.
CIRCULATION (2022)
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis
Han Zhu et al.
CIRCULATION (2022)
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis
Alexi Vasbinder et al.
JACC: CARDIOONCOLOGY (2022)
Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
Yanna Lei et al.
FRONTIERS IN PHARMACOLOGY (2022)
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
Joseph Nowatzke et al.
EUROPEAN JOURNAL OF CANCER (2022)
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure
Sarah Waliany et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents
Carlos Zamora et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Epicardial adipose tissue, inflammatory biomarkers and COVID-19: Is there a possible relationship?
Alireza Abrishami et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018
Gabriel E. Molina et al.
ONCOLOGIST (2021)
Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors
Despina Michailidou et al.
SCIENTIFIC REPORTS (2021)
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
Igor Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Julie R. Brahmer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure
Can Yao et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms
Samantha N. Champion et al.
MODERN PATHOLOGY (2020)
Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy
Irina Sobol et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
Chongxian Pan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis
Lili Zhang et al.
CIRCULATION (2020)
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis
Zsofia D. Drobni et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors
Alberto Pavana et al.
ONCOLOGIST (2019)
Myocarditis in the Setting of Cancer Therapeutics Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
Marc P. Bonaca et al.
CIRCULATION (2019)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
Javid J. Moslehi et al.
LANCET (2018)
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients
Matteo Sarocchi et al.
ONCOLOGIST (2018)
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita et al.
JAMA ONCOLOGY (2018)
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer
Mehdi Touat et al.
NEUROLOGY (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Myocarditis in auto-immune or auto-inflammatory diseases
Cloe Comarmond et al.
AUTOIMMUNITY REVIEWS (2017)
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
Yuanyuan Xiao et al.
BMC CANCER (2017)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis
Hua Zhang et al.
SCIENTIFIC REPORTS (2016)
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial
Andrew P. Ambrosy et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer
Yoshiaki Yamada et al.
ONCOLOGY REPORTS (2011)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2003)